Serum levels of protein HC and its IgA complex in malignant melanoma.

Protein HC is a low molecular weight glycoprotein that is present as free form and in complex with IgA (HC-IgA) in human body fluids. In the present report, a combined competitive and sandwich enzyme-linked immunsorbent assay (ELISA) was used to measure the levels of protein HC and its IgA complex independently in the sera of patients with malignant melanoma. The concentration of these proteins correlated with IgA levels and clinical staging. The main findings can be summarized as follows: (1) protein HC and protein HC-IgA complex levels presented the most significant elevation in melanoma stages IVA and IVB; (2) a significant positive correlation was found between protein HC and protein HC-IgA complex values and the clinical stage of the tumor; (3) protein HC-IgA complex and IgA concentrations are parameters with positive correlation both in normal controls and in patients with melanoma; (4) in normal sera, the levels of protein HC and protein HC-IgA complex are not correlated, however, they are negatively correlated in melanoma.

[1]  E. Shevach,et al.  Alpha1‐Microglobulin Is Mitogenic for Guinea Pig Lymphocytes , 1986, Scandinavian journal of immunology.

[2]  Y. Levo,et al.  Serum Amyloid P‐Component Levels in Patients with Malignancy , 1986, Scandinavian journal of immunology.

[3]  E. Méndez,et al.  Human protein HC and its IgA complex are inhibitors of neutrophil chemotaxis. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[4]  E. Méndez,et al.  A sensitive and rapid enzyme-linked immunosorbent assay using monoclonal antibodies for simultaneous quantitation of free and IgA-complexed protein HC. , 1985, Journal of immunological methods.

[5]  F. Leyva-Cobián,et al.  Defective monocyte chemotaxis and circulating immune complexes in selective IgA deficiency , 1985 .

[6]  L. Lögdberg,et al.  α1‐Microglobulin Glycopeptides Inhibit Antigen‐Specific Stimulation of Human Peripheral Blood Leucocytes , 1984, Scandinavian journal of immunology.

[7]  E. Unanue,et al.  Alpha-fetoprotein inhibits macrophage expression of Ia antigens. , 1984, Journal of immunology.

[8]  D. Cheresh,et al.  Interaction of an acute phase reactant, alpha 1-acid glycoprotein (orosomucoid), with the lymphoid cell surface: a model for non-specific immune suppression. , 1984, Immunology.

[9]  T. Appelboom,et al.  Leukocyte sensitization against synovial components in rheumatoid arthritis: blocking by pregnancy serum. , 1984, International archives of allergy and applied immunology.

[10]  E. Méndez,et al.  Isolation of human complex-forming glycoprotein, heterogeneous in charge (protein HC), and its IgA complex from plasma. Physiochemical and immunochemical properties, normal plasma concentration. , 1983, The Journal of biological chemistry.

[11]  Y. Shibata,et al.  In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in connection with its high level in tumor-bearing mice. , 1983, Cancer research.

[12]  T. Ikuta,et al.  Effect of α2-macroglobulin on the lymphocyte response , 1982 .

[13]  K. Meek,et al.  IgA containing immune complexes in dogs bearing a spontaneous mammary adenocarcinoma. , 1982, Clinical and experimental immunology.

[14]  L. Lögdberg,et al.  Immunosuppressive properties of alpha 1-microglobulin. , 1981, Scandinavian journal of immunology.

[15]  A. Cochran.  In vitro testing of the immune response , 1978 .

[16]  R. Snyderman,et al.  Abnormalities of Monocyte Chemotaxis in Patients With Melanoma: Effects of Immunotherapy and Tumor Removal , 1977 .

[17]  M. Romsdahl,et al.  IgA as a blocking factor in human malignant melanoma. , 1974, Immunological communications.

[18]  R. Winzler.  Plasma proteins in cancer. , 1953, Advances in cancer research.